Northern Trust Corp Atea Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 687,438 shares of AVIR stock, worth $2.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
687,438
Previous 661,284 3.96%
Holding current value
$2.21 Million
Previous $2.19 Million 5.21%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$3.17 - $4.02 $82,908 - $105,139
26,154 Added 3.96%
687,438 $2.3 Million
Q2 2024

Aug 14, 2024
SELL
$3.31 - $4.04 $86,010 - $104,979
-25,985 Reduced 3.78%
661,284 $2.19 Million
Q1 2024

May 14, 2024
SELL
$3.09 - $4.56 $74,913 - $110,552
-24,244 Reduced 3.41%
687,269 $2.78 Million
Q4 2023

Feb 13, 2024
BUY
$2.8 - $3.35 $127,010 - $151,959
45,361 Added 6.81%
711,513 $2.17 Million
Q3 2023

Nov 13, 2023
BUY
$3.0 - $3.79 $58,227 - $73,560
19,409 Added 3.0%
666,152 $2 Million
Q2 2023

Aug 11, 2023
SELL
$3.21 - $5.06 $187,146 - $295,003
-58,301 Reduced 8.27%
646,743 $2.42 Million
Q1 2023

May 15, 2023
SELL
$3.0 - $4.97 $17,682 - $29,293
-5,894 Reduced 0.83%
705,044 $2.36 Million
Q4 2022

Feb 13, 2023
SELL
$4.35 - $6.17 $62,152 - $88,156
-14,288 Reduced 1.97%
710,938 $3.42 Million
Q3 2022

Nov 14, 2022
BUY
$5.49 - $8.79 $176,229 - $282,159
32,100 Added 4.63%
725,226 $4.13 Million
Q2 2022

Aug 12, 2022
BUY
$5.33 - $8.18 $709,454 - $1.09 Million
133,106 Added 23.77%
693,126 $4.92 Million
Q1 2022

May 13, 2022
SELL
$5.5 - $9.19 $83,864 - $140,129
-15,248 Reduced 2.65%
560,020 $4.04 Million
Q4 2021

Feb 08, 2022
SELL
$7.67 - $44.59 $123,433 - $717,586
-16,093 Reduced 2.72%
575,268 $5.14 Million
Q3 2021

Nov 15, 2021
BUY
$21.33 - $35.06 $1.51 Million - $2.49 Million
70,939 Added 13.63%
591,361 $20.7 Million
Q2 2021

Aug 13, 2021
BUY
$19.22 - $59.08 $6.79 Million - $20.9 Million
353,262 Added 211.33%
520,422 $11.2 Million
Q1 2021

May 12, 2021
SELL
$41.42 - $88.44 $403,637 - $861,847
-9,745 Reduced 5.51%
167,160 $10.3 Million
Q4 2020

Feb 11, 2021
BUY
$26.36 - $41.78 $4.66 Million - $7.39 Million
176,905 New
176,905 $7.39 Million

Others Institutions Holding AVIR

# of Institutions
111
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $268M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email